CERE
State Street’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,109,886
| Closed | -$127M | – | 4394 |
|
|
2024
Q2 | $127M | Sell |
3,109,886
-418,584
| -12% | -$17.1M | 0.01% | 1117 |
|
|
2024
Q1 | $149M | Buy |
3,528,470
+676,651
| +24% | +$28.6M | 0.01% | 1056 |
|
|
2023
Q4 | $121M | Sell |
2,851,819
-48,516
| -2% | -$2.06M | 0.01% | 1166 |
|
|
2023
Q3 | $63.3M | Buy |
2,900,335
+132,058
| +5% | +$2.88M | ﹤0.01% | 1475 |
|
|
2023
Q2 | $88M | Sell |
2,768,277
-369,309
| -12% | -$11.7M | ﹤0.01% | 1311 |
|
|
2023
Q1 | $76.5M | Sell |
3,137,586
-286,634
| -8% | -$6.99M | ﹤0.01% | 1367 |
|
|
2022
Q4 | $108M | Buy |
3,424,220
+704,948
| +26% | +$22.2M | 0.01% | 1114 |
|
|
2022
Q3 | $76.8M | Buy |
2,719,272
+304,798
| +13% | +$8.61M | ﹤0.01% | 1295 |
|
|
2022
Q2 | $63.8M | Buy |
2,414,474
+252,378
| +12% | +$6.67M | ﹤0.01% | 1465 |
|
|
2022
Q1 | $75.7M | Sell |
2,162,096
-55,152
| -2% | -$1.93M | ﹤0.01% | 1492 |
|
|
2021
Q4 | $71.9M | Buy |
2,217,248
+55,476
| +3% | +$1.8M | ﹤0.01% | 1551 |
|
|
2021
Q3 | $63.8M | Buy |
2,161,772
+852,253
| +65% | +$25.1M | ﹤0.01% | 1623 |
|
|
2021
Q2 | $33.6M | Buy |
1,309,519
+377,383
| +40% | +$9.67M | ﹤0.01% | 2138 |
|
|
2021
Q1 | $12.8M | Buy |
+932,136
| New | +$12.8M | ﹤0.01% | 2620 |
|